Immunogenicity and Safety of One versus Two Doses of Quadrivalent Inactivated Influenza Vaccine (IIV4) in Vaccine-Unprimed Children and One Dose of IIV4 in Vaccine-Primed Children Aged 3–8 Years

Two doses of the inactivated influenza vaccine (IIV) are generally recommended for children under 9 years old. This study assessed the necessity for a second dose of quadrivalent IIV (IIV4) in children aged 3–8 years. In this randomized, open-label, paralleled-controlled study, 400 children aged 3–8...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Yunfeng, Yang, Wanqi, Li, Xiaoyu, Chu, Kai, Wang, Jianfeng, Tang, Rong, Xu, Li, Li, Lanshu, Hu, Yuansheng, Zhao, Chenyan, Pan, Hongxing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611167/
https://www.ncbi.nlm.nih.gov/pubmed/37896989
http://dx.doi.org/10.3390/vaccines11101586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611167/
https://www.ncbi.nlm.nih.gov/pubmed/37896989
http://dx.doi.org/10.3390/vaccines11101586

Ejemplares similares